1. So Far, PCSK9 Inhibitors Work for All Heterozygous FH Patients
by Markey C. McNutt, and Zahid Ahmad
Circ Genom Precis Med
Volume 8(6):
December 15, 2015
Copyright © American Heart Association, Inc. All rights reserved.

2. Low-density lipoprotein cholesterol (LDL-C) reduction achieved with PCSK9 inhibitors.
Low-density lipoprotein cholesterol (LDL-C) reduction achieved with PCSK9 inhibitors. FH indicates familial hypercholesterolemia.
Markey C. McNutt, and Zahid Ahmad Circ Cardiovasc Genet. 2015;8:
Copyright © American Heart Association, Inc. All rights reserved.